Federation of Infectious Diseases Societies of Southern Africa guideline: Recommendations for the detection, management and prevention of healthcare-associated Candida auris colonisation and disease in South Africa.

Candida auris has been detected at almost 100 South African hospitals, causing large outbreaks in some facilities, and this pathogen now accounts for approximately 1 in 10 cases of candidaemia. The objective of this guideline is to provide updated, evidence-informed recommendations outlining a best-practice approach to prevent, diagnose and manage C. auris disease in public- and private-sector healthcare settings in South Africa. The 18 practical recommendations cover five focus areas: laboratory identification and antifungal susceptibility testing, surveillance and outbreak response, infection prevention and control, clinical management and antifungal stewardship.
Competing Interests: All members of the guideline development group completed an International Committee of Medical Journal Editors (ICMJE) conflicts of interest form. Over the past 36 months, Adrian Brink served on speakers’ bureaus for Merck, Sharp & Dohm (MSD) South Africa and Pfizer. Warren Lowman received speaker fees from MSD South Africa, Pfizer and Astellas. Charlotte Sriruttan received a travel grant from MSD South Africa. For all other authors, no conflicts of interest were declared.
(© 2019. The Authors.)